Loutfy H. Madkour
RNA Delivery Function for Anticancer Therapeutics (eBook, ePUB)
72,95 €
72,95 €
inkl. MwSt.
Sofort per Download lieferbar
36 °P sammeln
72,95 €
Als Download kaufen
72,95 €
inkl. MwSt.
Sofort per Download lieferbar
36 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
72,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
36 °P sammeln
Loutfy H. Madkour
RNA Delivery Function for Anticancer Therapeutics (eBook, ePUB)
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book describes the status of clinical trials related to siRNA-based cancer therapy, as well as the remaining issues that need to be overcome to establish a successful therapy. It, then introduces various promising design strategies of delivery vehicles for stable and targeted siRNA delivery, including the prospects for future design.
- Geräte: eReader
- ohne Kopierschutz
- eBook Hilfe
- Größe: 19.61MB
Andere Kunden interessierten sich auch für
- Loutfy H. MadkourRNA Delivery Function for Anticancer Therapeutics (eBook, PDF)72,95 €
- Nanoconjugate Nanocarriers for Drug Delivery (eBook, ePUB)114,95 €
- Polymers in Drug Delivery (eBook, ePUB)61,95 €
- Rishi PaliwalNanomedicine, Nanotheranostics and Nanobiotechnology (eBook, ePUB)52,95 €
- Zahoor Ahmad ParryDendrimers in Medical Science (eBook, ePUB)87,95 €
- Bioinspired and Biomimetic Materials for Drug Delivery (eBook, ePUB)147,95 €
- Sarfaraz K. NiazimRNA Therapeutics (eBook, ePUB)49,95 €
-
-
-
This book describes the status of clinical trials related to siRNA-based cancer therapy, as well as the remaining issues that need to be overcome to establish a successful therapy. It, then introduces various promising design strategies of delivery vehicles for stable and targeted siRNA delivery, including the prospects for future design.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 424
- Erscheinungstermin: 25. Januar 2022
- Englisch
- ISBN-13: 9781000532241
- Artikelnr.: 63278975
- Verlag: Taylor & Francis
- Seitenzahl: 424
- Erscheinungstermin: 25. Januar 2022
- Englisch
- ISBN-13: 9781000532241
- Artikelnr.: 63278975
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Prof. Loutfy H. Madkour is a professor of physical chemistry and nanoscience at Tanta University (Egypt). He received his BSc, MSc, and PhD in physical chemistry from the Cairo, Minia, and Tanta universities in Egypt, respectively. He has published 200 peer-reviewed original research articles, 20 review articles, and 8 books. He is an editorial board member of several international journals, including International Journal of Industrial Chemistry (IJIC-Springer), International Journal of Ground Sediment & Water, Global Drugs and Therapeutics, Chronicles of Pharmaceutical Science, Journal of Targeted Drug Delivery, UPI Journal of Pharmaceutical, Medical and Health Sciences, Global Journal of Nanomedicine, Clinical Pharmacology and Toxicology Research, Journal of Pharmacology & Pharmaceutical Research, LOJ Pharmacology & Clinical Research, CPQ Medicine, Pharmaceutical Sciences & Analytical Research Journal, Japan Journal of Research, Organic & Medicinal Chemistry International Journal, Nanotechnology & Applications, Materials Science Journal, Journal of Chemical Science and Chemical Engineering (Journals of- JCSCE), United Journal of Nanotechnology and Medicine, Clinical Practice (Therapy) journal, Journal of Materials New Horizons, Journal of Radiology and Medical Imaging. MedDocs Publishers, World Journal of Pharmacy and Pharmaceutical Sciences WJPPS and Journal of Material Science and Technology Research - RBM.
Chapter 01
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human
cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment
targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel
biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi
therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer
cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer
therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer
cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic
targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small
molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in
cancer treatment nano-biotechnology
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human
cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment
targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel
biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi
therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer
cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer
therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer
cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic
targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small
molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in
cancer treatment nano-biotechnology
Chapter 01
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human
cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment
targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel
biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi
therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer
cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer
therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer
cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic
targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small
molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in
cancer treatment nano-biotechnology
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human
cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment
targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel
biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi
therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer
cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer
therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer
cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic
targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small
molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in
cancer treatment nano-biotechnology